CD7 and neoplasm: Once exposed to near-infrared light in tumor tissues, the anti-CD7-9R complexes within the fusion biomimetic carriers are released in response to structural decomposition and uptake by T cells due to receptor-mediated endocytosis based on CD7 and cell piercing peptide 9R.